References
- Diamandis EP. Mass spectrometry as a diagnostic and a cancer biomarker discovery tool: opportunities and potential limitations. Mol. Cell. Proteomics 3(4), 367–378 (2004).
- Banks RE, Stanley AJ, Cairns DA et al. Influences of blood sample processing on low-molecular-weight proteome identified by surface-enhanced laser desorption/ionization mass spectrometry. Influences of sample processing on low-molecular-weight proteome identified by surface-enhanced laser desorption/ionization mass spectrometry. Clin. Chem. 51(9), 1637–1649 (2005).
- Aivado M, Spentzos D, Alterovitz G et al. Optimization and evaluation of surface-enhanced laser desorption/ionization time-of-flight mass spectrometry (SELDI-TOF MS) with reversed-phase protein arrays for protein profiling. Clin. Chem. Lab. Med. 43(2), 133–140 (2005).
- Kiehntopf M, Osterloh D, Driesch D et al. Application of the SELDI ProteinChip system for the identification of distinct protein patterns in plasma from patients with noninfectious SIRS, infectious-induced SIRS and controls. In: NIH – Symposium on the Functional Genomics of Critical Illness and Injury. Bethesda, MD, USA (2003).
- Kiehntopf M, Osterloh D, von Eggeling F et al. SELDI-based protein patterns in the diagnosis of Sepsis/SIRS. In: Congress of Clinical Chemistry and Laboratory Medicine 2nd Annual Conference of the German United Society for Clinical Chemistry and Laboratory Medicine (DGKL) together with the Austrian Society for Laboratory Medicine and Clinical Chemistry (ÖGLMKC), Jena, Germany V22 (2005).
- Semler SC, Lux A, Dolle W, Reng M, Pommerening K. Pseudonymisierung für Forschungsdatenbanken und Register. In: Telemedizinführer Deutschland 2005. Jäckel A (Ed.), Ober-Mörlen, Medizin Forum , 209–14.2 (2004).
- Pommerening K, Reng M. Secondary use of the electronic health record via pseudonymisation. In: Medical Care Compunetics 1. Bos L, Laxminarayan S, Marsh A (Eds), IOS Press, Amsterdam, The Netherlands, 441–446 (2004).
- von Ahsen N, Armstrong VW, Behrens C et al. Association of inosine triphosphatase 94C>A and thiopurine S-methyltransferase deficiency with adverse events and study drop-outs under azathioprine therapy in a prospective Crohn disease study. Clin. Chem. 51(12), 2282–2288 (2005).
Website
- Nationaler Ethikrat www.ethikrat.org/stellungnahmen/stellungnahmen.html